New Wear Solutions from Abresist Suited to High Abrasion and Impact

Abresist Corporation, a Kalenborn Company, introduces 2 new KERAFLEX wear protection systems, consisting of ALRESIST® high alumina ceramics or KALMETALL®W hard overlay welding plates vulcanized to a steel base. These systems are well suited where high abrasion and impact occur in combination. Maximum operating temperature is 176º F / 80º C.

KERAFLEX reduces noise and is especially well suited for use in transfer chutes in belt conveyor systems and impact zones in bunkers and silos. These wear protection systems are produced in standard panels, up to 20” square, with welded studs or countersunk bolting attachments.

KERAFLEX-KRM consists of ALRESIST® high alumina ceramics with a tile thickness of ½” or 1”. The thickness of the rubber is determined by the severity of the impact. KERAFLEX-WRM consists of KALMETALL-W hard overlay welded plates, rubber and steel. KERAFLEX-KR, with 1/8” to 1/2” thick ALRESIST® tile and a rubber backing only, provides for a flexible lining that is glued in place.

Abresist Corporation will be attending the Electric Power show in Booth No. 921 from May 12-14, 2009 in Rosemont, IL.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kalenborn Abresist Corporation. (2019, February 10). New Wear Solutions from Abresist Suited to High Abrasion and Impact. AZoM. Retrieved on May 18, 2024 from https://www.azom.com/news.aspx?newsID=15502.

  • MLA

    Kalenborn Abresist Corporation. "New Wear Solutions from Abresist Suited to High Abrasion and Impact". AZoM. 18 May 2024. <https://www.azom.com/news.aspx?newsID=15502>.

  • Chicago

    Kalenborn Abresist Corporation. "New Wear Solutions from Abresist Suited to High Abrasion and Impact". AZoM. https://www.azom.com/news.aspx?newsID=15502. (accessed May 18, 2024).

  • Harvard

    Kalenborn Abresist Corporation. 2019. New Wear Solutions from Abresist Suited to High Abrasion and Impact. AZoM, viewed 18 May 2024, https://www.azom.com/news.aspx?newsID=15502.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.